Hsbc Holdings PLC boosted its stake in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 33.8% during the 2nd quarter, according to its most recent filing with the SEC. The firm owned 676,554 shares of the real estate investment trust's stock after purchasing an additional 170,974 shares during the period. Hsbc Holdings PLC owned approximately 0.26% of Sabra Healthcare REIT worth $13,261,000 at the end of the most recent quarter.
A number of other institutional investors have also modified their holdings of SBRA. PNC Financial Services Group Inc. grew its holdings in Sabra Healthcare REIT by 2.3% during the fourth quarter. PNC Financial Services Group Inc. now owns 23,807 shares of the real estate investment trust's stock worth $451,000 after acquiring an additional 528 shares during the period. Larson Financial Group LLC boosted its position in Sabra Healthcare REIT by 42.3% in the 3rd quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust's stock worth $35,000 after purchasing an additional 553 shares in the last quarter. Inspire Investing LLC grew its stake in shares of Sabra Healthcare REIT by 2.3% during the 4th quarter. Inspire Investing LLC now owns 24,747 shares of the real estate investment trust's stock worth $469,000 after purchasing an additional 565 shares during the period. Natixis Advisors LLC grew its stake in shares of Sabra Healthcare REIT by 2.2% during the 3rd quarter. Natixis Advisors LLC now owns 27,664 shares of the real estate investment trust's stock worth $516,000 after purchasing an additional 598 shares during the period. Finally, Versant Capital Management Inc increased its holdings in shares of Sabra Healthcare REIT by 70.0% during the 2nd quarter. Versant Capital Management Inc now owns 1,465 shares of the real estate investment trust's stock valued at $29,000 after purchasing an additional 603 shares in the last quarter. Hedge funds and other institutional investors own 99.40% of the company's stock.
Analysts Set New Price Targets
Several analysts recently commented on SBRA shares. Mizuho set a $21.00 price target on shares of Sabra Healthcare REIT in a research report on Monday, August 31st. Scotiabank lowered their target price on shares of Sabra Healthcare REIT from $22.00 to $19.00 and set a "sector perform" rating on the stock in a research note on Thursday, June 18th. Citigroup restated a "market outperform" rating on shares of Sabra Healthcare REIT in a research note on Wednesday, July 22nd. Weiss Ratings cut Sabra Healthcare REIT from a "buy (b)" rating to a "hold (c+)" rating in a report on Tuesday, August 4th. Finally, Wall Street Zen raised Sabra Healthcare REIT from a "sell" rating to a "hold" rating in a report on Sunday, June 28th. Six research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. Based on data from MarketBeat, Sabra Healthcare REIT currently has an average rating of "Hold" and a consensus price target of $22.17.
View Our Latest Stock Analysis on SBRA
Sabra Healthcare REIT Price Performance
Shares of NASDAQ SBRA opened at $20.81 on Wednesday. The firm has a 50-day simple moving average of $20.66 and a 200-day simple moving average of $20.20. The company has a quick ratio of 3.07, a current ratio of 3.07 and a debt-to-equity ratio of 0.95. The stock has a market capitalization of $5.32 billion, a price-to-earnings ratio of 80.04, a price-to-earnings-growth ratio of 1.58 and a beta of 0.65. Sabra Healthcare REIT, Inc. has a 52 week low of $17.17 and a 52 week high of $22.77.
Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last announced its quarterly earnings data on Monday, August 3rd. The real estate investment trust reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.17 by ($0.27). Sabra Healthcare REIT had a net margin of 7.61% and a return on equity of 2.34%. The business had revenue of $230.11 million for the quarter, compared to analysts' expectations of $219.39 million. During the same period in the prior year, the company posted $0.38 EPS. The firm's revenue was up 24.7% on a year-over-year basis. On average, equities analysts predict that Sabra Healthcare REIT, Inc. will post 1.52 earnings per share for the current fiscal year.
Sabra Healthcare REIT Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Monday, August 31st. Stockholders of record on Friday, August 14th were given a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, August 14th. This represents a $1.20 annualized dividend and a dividend yield of 5.8%. Sabra Healthcare REIT's payout ratio is presently 461.54%.
Sabra Healthcare REIT Profile
(
Free Report)
Sabra Healthcare REIT, Inc NASDAQ: SBRA is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.
Serving a broad spectrum of care segments, Sabra's tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.
Recommended Stories
Want to see what other hedge funds are holding SBRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Sabra Healthcare REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Healthcare REIT wasn't on the list.
While Sabra Healthcare REIT currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.